The Ledger
Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.
why aren't all 8 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable
Lyon: Private equity falsely held 2022 valuations flat despite public market plunges
“If you looked at 2022, the S&P was down 20%. The NASDAQ was down 30%. Let's say private equity lives somewhere between those two worlds. Private equity was flat for the year.”
Grantham: Oil dropping to 2.5% of S&P is largest historic sector loss
“Oil as a percentage of the S&P had come down from 25% in 1982 and 16% in oh eight to two and a half percent yesterday. This is the biggest loss of value in the history of the major groups of the S&P that goes all the way back into the 20.”
O'Shaughnessy: S&P 500 still beats hedge funds on a Sharpe ratio basis
“I think on Sharpe ratio, it still would have been the S&P.”
Khoury: Real Estate Is the Only S&P Sector Down Since 2022
“You're talking to somebody who's investing in the only GIC sector in the S&P that's still materially down since 22. The GIC and REITs is down almost 20%, while the S&P is up 40. We've now, since the beginning of 22, underperformed the S&P by 60%. I believe the…”
André Perold: S&P 500 gained 9% annually since 2005, 3% from multiples
“You know, the last 15 years that we've been in business, if you look at the return on the S&P, it's nine percent a year since the late 2005. Of the nine, three percent a year has come from multiple expansion, and that three percent a year is entirely consisten…”
Biotech underperformed tech and matched the S&P 500 over five years
“It's interesting that if you go look at the biotech industry relative or any of the small cap biotech industries relative to the NASDAQ or relative to the S&P, they've underperformed the NASDAQ, so they've underperformed tech the last four or five years. They'…”